Ypsomed Holding AG
YPSN
Peringkat dalam Saham
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Harga Saham
$469.39
Kapitalisasi Pasar
$6.17B
Perubahan (1 hari)
1.63%
Perubahan (1 tahun)
18.98%
Negara
CH
Perdagangan Ypsomed Holding AG (YPSN)
Kategori
Healthcare
Rasio P/E untuk Ypsomed Holding AG (YPSN)
Rasio P/E per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Ypsomed Holding AG, rasio P/E saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki rasio P/E sebesar 0.
Riwayat rasio P/E untuk Ypsomed Holding AG dari 2002 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2025 | 52.96 | -14.36% |
| 2024 | 61.85 | 22.83% |
| 2023 | 50.35 | -43.56% |
| 2022 | 89.21 | -74.08% |
| 2021 | 344.22 | 156.38% |
| 2020 | 134.26 | 397.39% |
| 2019 | 26.99 | -23.24% |
| 2018 | 35.17 | -32.11% |
| 2017 | 51.80 | 7.19% |
| 2016 | 48.33 | -18.25% |
| 2015 | 59.12 | -17.99% |
| 2014 | 72.08 | -82.56% |
| 2013 | 413.31 | 406.81% |
| 2012 | 81.55 | -40.99% |
| 2011 | 138.21 | 59.97% |
| 2010 | 86.40 | 183.61% |
| 2009 | 30.46 | -15.15% |
| 2008 | 35.90 | -90.80% |
| 2007 | 390.29 | 859.06% |
| 2006 | 40.70 | 23.88% |
| 2005 | 32.85 | 103.69% |
| 2004 | 16.13 | 3.77% |
| 2003 | 15.54 | -89.36% |
| 2002 | 146.00 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 26.50 | - |
IE
|
|
| 81.39 | - |
CN
|
|
| - | - |
CH
|
|
| 22.17 | - |
CN
|
|
| 19.80 | - |
KR
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.